Ausgabe 1/2005
Inhalt (9 Artikel)
Allogeneic hematopoietic cell transplantation: from experimental biology to clinical care
Razvan Diaconescu, Rainer Storb
Expression of e-cadherin in high-risk breast cancer
Eugene M. Howard, Stephen K. Lau, Robert H. Lyles, George G. Birdsong, Jay N. Umbreit, Ruby Kochhar
A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer
Shunji Matsumura, Naohide Oue, Hirofumi Nakayama, Yasuhiko Kitadai, Kazuhiro Yoshida, Yoshiyuki Yamaguchi, Kazue Imai, Kei Nakachi, Keisuke Matsusaki, Kazuaki Chayama, Wataru Yasui
Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy of glioblastoma multiforme
Jochen Tuettenberg, Rainer Grobholz, Tobias Korn, Frederik Wenz, Ralf Erber, Peter Vajkoczy
Increased expression of ADAM family members in human breast cancer and breast cancer cell lines
Uwe Lendeckel, Jana Kohl, Marco Arndt, Stacy Carl-McGrath, Hans Donat, Christoph Röcken
Listeria monocytogenes produces a pro-invasive factor that signals via ErbB2/ErbB3 heterodimers
Maria José Oliveira, Tineke Lauwaet, Georges De Bruyne, Marc Mareel, Ancy Leroy
The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain
Knut Liepe, Roswitha Runge, Jörg Kotzerke
Clinical response to induction chemotherapy predicts local control and long-term survival in multimodal treatment of patients with locally advanced esophageal cancer
Michael Stahl, Hansjochen Wilke, Martin Stuschke, Martin K. Walz, Ulrich Fink, Michael Molls, J. Rüdiger Siewert, Michael Schroeder, Hans-Bruno Makoski, Ulrich Schmidt, Siegfried Seeber, Udo Vanhoefer